Cases & Deals

Genomic Vision completes IPO on regulated market of Euronext in Paris

Clients Genomic Vision SA; Société Générale Corporate and Investment Banking; and Bryan, Garnier & Co.

Jones Day advised Genomic Vision SA, a molecular diagnostics company that develops and markets diagnostic tests based on analyzing individual DNA molecules, along with underwriters Société Générale Corporate and Investment Banking and Bryan, Garnier & Co., in connection with the €25.8 million (US$35.6 million) initial public offering of New Shares on the regulated market of Euronext in Paris.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.